Phase II treatment of adults with primary malignant glioma with irinotecan plus temozolomide.

Trial Profile

Phase II treatment of adults with primary malignant glioma with irinotecan plus temozolomide.

Completed
Phase of Trial: Phase II

Latest Information Update: 18 Jun 2013

At a glance

  • Drugs Irinotecan; Temozolomide
  • Indications Glioblastoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Aug 2010 Actual end date (Jun 2009) added as reported by ClinicalTrials.gov.
    • 19 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 22 Jan 2009 Additional trial investigator identified as reported by ClinicalTrials.gov, last updated 22 Jan 2009
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top